Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Dehydrocorydaline chloride
Cat. No.:
OB0225LY-0358
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Product Overview
Description:
Dehydrocorydaline chloride is an alkaloid with anti-inflammatory and analgesic properties.
Synonym:
13-Methylpalmatine chloride; 10605-03-5; Dehydrocorydaline (chloride); 2,3,9,10-Tetramethoxy-13-methyl-5,6-dihydroisoquinolino[2,1-b]isoquinolin-7-ium; chloride; 2,3,9,10-Tetramethoxy-13-methyl-5,6-dihydroisoquinolino[3,2-a]isoquinolin-7-ium chloride
CAS No.:
10605-03-5
Compound CID:
160950
Formula:
C22H24ClNO4
Formula Weight:
401.88
Specification
Relative Density:
1.23 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Dehydrocorydaline chloride can be used to study analgesic mechanisms or play an important role in neuroscience research.
Library Information
Targets:
BCL family; PARP family; Caspase family; MAPK family
Receptors:
Bax; Bcl-2; Bcl-2 Family; Caspase-7; Caspase-8; p38 MAPK
Pathways:
DNA damage/DNA repair; MAPK; Apoptosis; Autophagy; Chromatin/Epigenetic; Proteases/Proteasome; Microbiology/Virology
Plate Number:
AOCL-5
Plate Location:
f3
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
24 mg/mL; 59.72 mM
